C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2001
10/18/2001	WO2000037635A3 Genetic suppressor elements against human immunodeficiency virus
10/18/2001	US20010032344 Fertile transgenic corn plants
10/18/2001	US20010032342 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase for improvement and optimization of plant phenotypes
10/18/2001	US20010032341 Modification of the expression of UDP-glucose 4-epimerase may result in grains with reduced fiber and increased levels of starch thus adding value for feed, food, and industrial applications of crops
10/18/2001	US20010032339 Chaperone suppression of ataxin-1 aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1
10/18/2001	US20010032337 Introduction of exogenous nucleotide sequences into a genome by microinjection of infectious retrovirus into the perivitelline space of the egg; making a bovine embryo; use to confer disease resistance, for example
10/18/2001	US20010032052 Apparatus and method for automated protein design
10/18/2001	US20010032016 Method for in vitro production of bone
10/18/2001	US20010032015 In vitro modification of cardiac valvular xenografts
10/18/2001	US20010031859 Human cell line characterized by expression of code sequence for antiapoptotic protein and level of cytokine production twice that of of cytokine production exhibited by parental cell line that does not express code for antiapoptotic protein
10/18/2001	US20010031740 Mixture containing organic halide
10/18/2001	US20010031496 Compositions and methods for plant transformation and regeneration
10/18/2001	US20010031485 Nucleic acid coding for fusion protein which binds receptor; internalized by endocytosis; inhibits ribosomes and angiogenesis; therapy for tumors, metastasis, eye disorders, chronic inflammation and ischemic injuries
10/18/2001	US20010031476 Determining rate of bone resorption by measuring peptides in body fluid having 3-hydroxypyridinium cross-link; diagnostic tool for Paget's disease
10/18/2001	US20010031474 Chimeric neuropeptide Y receptors
10/18/2001	US20010031470 Using the depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of a predetermined nucleic acid; detection of single nucleotide polymorphisms, speciation, viral load, genotyping
10/18/2001	US20010031256 Vision defects
10/18/2001	US20010031255 Culture product
10/18/2001	US20010031253 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
10/18/2001	DE10015906A1 Directed gene transfer to eukaryotic cells, useful for antisense inhibition of specific genes, comprises using a complex of polyethyleneimine, nucleic acid and monoclonal antibodies
10/18/2001	DE10011481A1 Adsorbens zum Absenken der Konzentration von Fibrinogen und/oder Fibrin, Verwendung des Adsorbens zur Herstellung eines Adsorbers und Adsorber mit dem Adsorbens Adsorbent for lowering the concentration of fibrinogen and / or fibrin, using the adsorbent for producing an adsorber and the adsorber with the adsorbent
10/18/2001	DE10007234A1 Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems Peptide and nucleic acid coding for determining diagnosis and treatment of diseases of the nervous system
10/18/2001	CA2789254A1 Signal transduction stress-related proteins and methods of use in plants
10/18/2001	CA2785943A1 Protein kinase stress-related proteins and methods of use in plants
10/18/2001	CA2767275A1 Cell cycle stress-related proteins and methods of use in plants
10/18/2001	CA2767239A1 Transcription factor stress-related proteins and methods of use in plants
10/18/2001	CA2414652A1 Animal and cell models for type ii diabetes and their use
10/18/2001	CA2406448A1 Identification of a human gaba transporter
10/18/2001	CA2406366A1 Muir-torre-like syndrome infhit deficient mice
10/18/2001	CA2406033A1 Anti-d monoclonal antibodies
10/18/2001	CA2405912A1 Albumin fusion proteins
10/18/2001	CA2405870A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia
10/18/2001	CA2405806A1 A method to prevent graft rejection using tgf-.beta. to induce t suppressor cells
10/18/2001	CA2405800A1 Novel secreted protein
10/18/2001	CA2405730A1 Serine-threonine kinase
10/18/2001	CA2405725A1 Identification of a novel dual specificity phosphataes
10/18/2001	CA2405311A1 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/18/2001	CA2405181A1 Human pyruvate dehydrogenese phosphatase
10/18/2001	CA2405124A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof
10/18/2001	CA2405104A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	CA2405083A1 New bromodomain protein
10/18/2001	CA2404988A1 Listeria monocytogenes genome, polypeptides and uses
10/18/2001	CA2404971A1 Human protein kinases and protein kinase-like enzymes
10/18/2001	CA2404779A1 Human lipid binding protein 1
10/18/2001	CA2404634A1 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof
10/18/2001	CA2404313A1 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
10/18/2001	CA2404265A1 Human ovarian mesothelial cells and methods of isolation and uses thereof
10/18/2001	CA2404229A1 Human transporters and ion channels
10/18/2001	CA2403946A1 Genes expressed in foam cell differentiation
10/18/2001	CA2403425A1 Multivalent antibodies and uses therefor
10/18/2001	CA2403003A1 T2r taste receptors and genes encoding same
10/18/2001	CA2402410A1 The high bone mass gene of 11q13.3
10/18/2001	CA2402195A1 Signal sequence trapping
10/18/2001	CA2400746A1 Method of producing adenoviral vector stocks
10/17/2001	EP1146120A1 Method for obtaining specific T-lymphocites, and for identifying etitopes
10/17/2001	EP1146119A1 Method for obtaining specific T-lymphocytes, and for identifying unknown epitopes
10/17/2001	EP1146118A1 Organs for transplantation induced in vitro
10/17/2001	EP1146117A1 A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus
10/17/2001	EP1146056A1 Antibodies which activate an erythropoietin receptor
10/17/2001	EP1145011A2 Compositions and methods for the diagnosis and treatment of tumor
10/17/2001	EP1144999A1 Method and device for the cell-track-based examination and cultivation of cells
10/17/2001	EP1144671A2 Enriched central nervous system cell populations
10/17/2001	EP1144665A1 Methods for transforming plastids
10/17/2001	EP1144661A2 Method of genetic modification of a wild type viral sequence
10/17/2001	EP1144655A2 Regulated expression using conditional er retention domains
10/17/2001	EP1144652A1 Manipulating isoprenoid expression
10/17/2001	EP1144651A1 Polypeptides derived from jnk3
10/17/2001	EP1144650A2 Goodpasture antigen binding protein
10/17/2001	EP1144648A1 Cyclic nucleotide-associated proteins
10/17/2001	EP1144647A2 Method of improving the primary energy metabolism of mammalian cell lines
10/17/2001	EP1144645A1 Neisseria meningitidis polypeptide basb052
10/17/2001	EP1144644A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
10/17/2001	EP1144642A2 Compounds and methods for treatment and diagnosis of chlamydial infection
10/17/2001	EP1144636A2 Human genes and gene expression products
10/17/2001	EP1144634A2 Novel complex-forming proteins
10/17/2001	EP1144633A1 Polypeptide
10/17/2001	EP1144632A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/17/2001	EP1144631A2 Insulin-synthesis genes
10/17/2001	EP1144630A2 Human cell signaling proteins (csig)
10/17/2001	EP1144629A2 Further pro polypeptides and sequences thereof
10/17/2001	EP1144628A2 Human vanilloid receptor gene
10/17/2001	EP1144626A2 Methods of monitoring hiv drug resistance
10/17/2001	EP1144625A2 Nucleic-acid binding proteins
10/17/2001	EP1144621A2 Genetic suppressor elements against human immunodeficiency virus
10/17/2001	EP1144617A2 Cancer-associated proteins
10/17/2001	EP1144614A2 33 human secreted proteins
10/17/2001	EP1144611A2 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin
10/17/2001	EP1144608A2 Synthetic vectors, transgenic plants containing them, and methods for obtaining them
10/17/2001	EP1144607A2 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
10/17/2001	EP1144605A2 Dimethylarginine dimethylaminohydrolases
10/17/2001	EP1144600A2 Akt-3 nucleic acids, polypeptides, and uses thereof
10/17/2001	EP1144598A2 Human homologues of proteins regulated by circadian rhythms
10/17/2001	EP1144597A2 Immortalized cell lines and methods of making the same
10/17/2001	EP1144596A2 Application of shear flow stress to smooth muscle cells for the production of implantable structures
10/17/2001	EP1144595A2 Platform for the differentiation of cells
10/17/2001	EP1144594A1 Transgenic circulating endothelial cells
10/17/2001	EP1144593A1 Compositions isolated from plant cells and their use in the modification of plant cell signaling
10/17/2001	EP1144592A2 Substrate for cell growth
10/17/2001	EP1144591A2 Low oxygen culturing of cells
10/17/2001	EP1144590A1 Compartmentalization of recombinant polypeptides in host cells

1 ... 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 ... 1827